Compound Heterozygosity for Late-Onset Cardiomyopathy-Causative ALPK3 Coding Variant and Novel Intronic Variant Cause Infantile Hypertrophic Cardiomyopathy

Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: an overview. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22147722. (MDPI)

Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013. https://doi.org/10.1016/S0140-6736(12)60397-3. (Elsevier B.V)

Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017. https://doi.org/10.1016/S0140-6736(16)31713-5. (Lancet Publishing Group)

Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, Lipshultz SE. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010. https://doi.org/10.1016/j.hfc.2010.05.002.

Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, Lipshultz SE. treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol. 2009;104(2):281–6. https://doi.org/10.1016/j.amjcard.2009.03.033.

Article  PubMed  PubMed Central  Google Scholar 

Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, Lipshultz SE. Pediatric cardiomyopathies. Circ Res. 2017;121(7):855–73. https://doi.org/10.1161/CIRCRESAHA.116.309386.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tariq M. Importance of genetic evaluation and testing in pediatric cardiomyopathy. World J Cardiol. 2014;6(11):1156. https://doi.org/10.4330/wjc.v6.i11.1156.

Article  PubMed  PubMed Central  Google Scholar 

Towbin JA. Inherited cardiomyopathies. Circ J. 2014;78(10):2347–56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467885

Van Sligtenhorst I, Ding ZM, Shi ZZ, Read RW, Hansen G, Vogel P. Cardiomyopathy in α-kinase 3 (Alpk3)-deficient mice. Vet Pathol. 2012;49(1):131–41. https://doi.org/10.1177/0300985811402841.

Article  CAS  PubMed  Google Scholar 

Herkert JC, Verhagen JMA, Yotti R, Haghighi A, Phelan DG, James PA, van de Laar IMBH. Expanding the clinical and genetic spectrum of ALPK3 variants: phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants. Am Heart J. 2020;225:108–19. https://doi.org/10.1016/j.ahj.2020.03.023.

Article  CAS  PubMed  Google Scholar 

Almomani R, Verhagen JMA, Herkert JC, Brosens E, Van Spaendonck-Zwarts KY, Asimaki A, Van De Laar IMBH. Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy. J Am Coll Cardiol. 2016;67(5):515–25. https://doi.org/10.1016/j.jacc.2015.10.093.

Article  CAS  PubMed  Google Scholar 

Çağlayan AO, Sezer RG, Kaymakçalan H, Ulgen E, Yavuz T, Baranoski JF, Gunel M. ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features. Cold Spring Harb Mol Case Stud. 2017;3(5). https://doi.org/10.1101/mcs.a001859.

Jaouadi H, Kraoua L, Chaker L, Atkinson A, Delague V, Levy N, Zaffran S. Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features. J Hum Genet. 2018;63(10):1077–82. https://doi.org/10.1038/s10038-018-0492-1.

Article  CAS  PubMed  Google Scholar 

Al Senaidi K, Joshi N, Al-Nabhani M, Al-Kasbi G, Al Farqani A, Al-Thihli K, Al-Maawali A. Phenotypic spectrum of ALPK3-related cardiomyopathy. Am J Med Genet A. 2019;179(7):1235–40. https://doi.org/10.1002/ajmg.a.61176.

Article  CAS  PubMed  Google Scholar 

Lopes LR, Garcia-Hernández S, Lorenzini M, Futema M, Chumakova O, Zateyshchikov D, Elliott PM. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy. Eur Heart J. 2021;42(32):3063–73. https://doi.org/10.1093/eurheartj/ehab424.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Bainbridge MN, Tan Y, Willerson JT, Marian AJ. A potential oligogenic etiology of hypertrophic cardiomyopathy: a classic single-gene disorder. Circ Res. 2017;120(7):1084–90. https://doi.org/10.1161/CIRCRESAHA.116.310559.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agarwal R, Wakimoto H, Paulo JA, Zhang Q, Reichart D, Toepfer C, Seidman CE. Pathogenesis of cardiomyopathy caused by variants in ALPK3, an essential pseudokinase in the cardiomyocyte nucleus and sarcomere. Circulation. 2022. https://doi.org/10.1161/circulationaha.122.059688.

Comments (0)

No login
gif